Dynavit D3

Quick links to important sections

Dynavit D3

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dynavit D3

SECTION OVERVIEW: WHAT IS DYNAVIT D3?

Property Description
Active Ingredient Colecalciferol (Vitamin D3)
Form Oral Solution (Liquid Drops), Spray, Tablet, Sachet
Pharmacological Class Vitamin D Analog; Secosteroid
General Purpose Supports calcium/phosphorus absorption and bone integrity
Origin Derived (Prohormone; exogenous supplement)

What Type of Preparation is Dynavit D3 (Colecalciferol)?

Dynavit D3 is a commercial preparation providing Colecalciferol, the official nonproprietary name for Vitamin D3, which functions within the body as a prohormone. It is classified as a fat-soluble vitamin and belongs to the Vitamin D analog pharmacological class, chemically identified as a secosteroid. This compound is the same form synthesized naturally in human skin upon adequate sunlight exposure.

As a single-ingredient product, this supplement is generally designed for oral intake. This classification signifies that it is a powerful regulatory substance that the body converts into the active hormone, calcitriol, which is clinically recognized for its essential role in systemic function.


What is the Composition and Form of Dynavit D3?

The active component is Colecalciferol, available in several distinct oral dosage forms, including liquid drops (oral solution), spray, tablets, and powder sachets. The availability of these forms provides flexibility for administration, particularly for individuals requiring low-volume dosing.

The composition involves the active Colecalciferol suspended in a suitable base/vehicle, such as an oil or aqueous solution, alongside inactive excipients. The general purpose of this supplement is often centered on bone health support and the enhancement of immune system function.


What is the General Purpose of Colecalciferol?

The overarching purpose of Colecalciferol is to maintain mineral homeostasis, a crucial balance that governs the availability of key elements in the body. It does this by significantly promoting the intestinal absorption of dietary calcium and phosphorus.

This regulatory function is necessary for building and maintaining strong bones, thereby helping to ensure skeletal integrity, and supporting overall physiological functions, including healthy immune system and proper muscle tissue performance.

Regulatory References

  1. Cholecalciferol - StatPearls - NCBI Bookshelf

What side effects are possible with Dynavit D3?

Possible side effects and safety information

The official safety profile for Colecalciferol (Vitamin D3) primarily documents the potential for effects related to mineral homeostasis and various hypersensitivity reactions. The most common adverse reactions are related to an imbalance in calcium levels, which are formally classified by regulatory agencies.


Official Adverse Reactions and Frequencies

Adverse reactions are classified by frequency according to regulatory documentation:

Classification System-Organ Class Reactions
Uncommon Metabolism and Nutrition Disorders Hypercalcaemia (high blood calcium), Hypercalciuria (high urine calcium)
Rare Skin and Subcutaneous Tissue Disorders Pruritus (itching), Rash, Urticaria (hives)
Frequency Not Known Immune System Disorders Hypersensitivity reactions (e.g., angio-oedema)

Serious Safety Considerations

The most serious safety concerns documented in regulatory labeling are associated with excessive or prolonged intake, potentially leading to Hypervitaminosis D (Vitamin D toxicity). This overexposure risk includes the potential for long-term consequences such as Nephrocalcinosis (kidney calcification) or Nephrolithiasis (kidney stones), outcomes linked to chronic, persistent hypercalcaemia.


Population and Constraint Notes

The use of Colecalciferol is restricted in individuals with pre-existing conditions such as Hypercalcaemia, Hypervitaminosis D, or Nephrolithiasis. Specific safety precautions are required for patients with renal impairment and sarcoidosis, where close monitoring of calcium levels is noted in official documentation. Caution is also advised for patients using certain interacting medicines, as this may increase the risk of elevated calcium levels.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information for Dynavit D3 (Colecalciferol)

An overdose of Colecalciferol (Dynavit D3) can result in a state of hypervitaminosis D, which is primarily characterized by the development of hypercalcemia (abnormally high blood calcium levels). According to regulatory documents, individuals must seek immediate medical attention and contact emergency services or a Poison Control Center if an overdose is suspected.

Documented Overdose Manifestations

Classification Signs and Symptoms (as listed in official labeling)
Initial Symptoms Nausea, vomiting, anorexia, polyuria, polydipsia, weakness, and fatigue.
Severe Outcomes Risk of cardiac arrhythmias, renal impairment (including nephrocalcinosis and renal failure), and vascular/soft tissue calcification.

Emergency Actions and Management

Upon confirmed or suspected overdose, the primary action required is the immediate discontinuation of Colecalciferol treatment. Management is defined by regulatory authorities as symptomatic and supportive treatment because no specific antidote is known. Procedures include rehydration and measures to reduce serum calcium, such as dietary restriction or the use of specific medications. Severe cases necessitate hospital monitoring, including frequent assessment of serum calcium and renal function, especially given the heightened risk reported for infants and children.

Therapeutic Uses of Dynavit D3

What Dynavit D3 Treats: Main Uses and Benefits

Dynavit D3, containing cholecalciferol (Vitamin D3), is commonly used for managing symptoms related to systemic imbalance stemming from Vitamin D deficiency. This deficiency is a condition where functional stability becomes affected, primarily impacting bone health and contributing to systemic imbalance.

The core therapeutic domain for Vitamin D3 is applied across situations involving certain distressing symptoms, relevant for easing symptoms that interfere with daily comfort. It is used as a supplement to help address symptom clusters that may become intense or disruptive in conditions where symptoms may intensify temporarily, such as rickets in children, osteomalacia (softening of the bones) in adults, and its use as an adjunct to specific treatments for osteoporosis (thinning bones).

The supplement plays a role in managing symptoms that create noticeable physiological strain and helps maintain a sense of stability when symptoms are more noticeable. It supports patients during episodes of heightened discomfort and provides supportive relief when symptoms interfere with routine activities. For this reason, the use of cholecalciferol contributes to easing the overall symptom load.

Quick Fact: Supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Who Can and Cannot Use Dynavit D3?

The official eligibility profile for Colecalciferol (Dynavit D3) defines who can use the medicine based on metabolic status and specific health conditions.

Contraindications and Restrictions

Eligibility Status Affected Population or Condition
Absolutely Contraindicated Patients with Hypercalcaemia (high blood calcium), Hypercalciuria (high urine calcium), or Hypervitaminosis D (existing high Vitamin D levels) [Source 1.1].
Patients with severe renal impairment [Source 1.2].
Conditional Use Only Patients with Sarcoidosis or those who are immobilized require caution due to the risk of heightened calcium levels [Source 1.1].
Not Recommended High-dose formulations are not recommended during pregnancy or lactation due to potential risks of hypercalcaemia; supplementary low doses are typically accepted [Source 2.1].

Age and Organ Status

Adults and the pediatric population (infants, children, and adolescents) are generally permitted for use, though the appropriate formulation and strength must be determined for children [Source 1.2]. High-strength capsules are often restricted for those under 12 years of age. Hepatic impairment does not typically require a dose adjustment. However, renal impairment requires close monitoring of calcium levels, and severe impairment is an absolute contraindication [Source 1.5].

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Colecalciferol (Dynavit D3) is documented in regulatory sources and primarily centers on substances that interfere with its absorption or metabolism, or those that create an additive effect on calcium levels.

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substances Official Interaction Pattern
Anticonvulsants (e.g., Phenytoin, Phenobarbital) and Rifampicin May reduce the effectiveness of Colecalciferol due to increased metabolic breakdown (hepatic enzyme induction).
Bile Acid Sequestrants (e.g., Cholestyramine) and Mineral Oil Laxatives Impairs the absorption of Colecalciferol, which is a fat-soluble compound.
Thiazide Diuretics (e.g., Bendroflumethiazide) Increases the risk of hypercalcaemia (elevated serum calcium) due to an additive pharmacodynamic effect.
Cardiac Glycosides (e.g., Digoxin) Elevated calcium levels can exacerbate toxicity and arrhythmias from the cardiac glycoside.

Restrictions and Population-Specific Notes

Co-administration with Glucocorticoids may officially decrease the effect of Colecalciferol. Products containing Magnesium may pose a risk of hypermagnesaemia when administered to patients with Chronic Renal Dialysis conditions. To ensure adequate exposure, administration may require separation from substances known to impair absorption. Combining Colecalciferol with other Vitamin D metabolites or high doses of calcium supplements requires close monitoring for additive effects as stated in official prescribing information.

Mechanism of Action

The mechanism of Dynavit D3 (Colecalciferol) relies on its function as a prohormone, requiring sequential enzymatic activation in the liver and kidney to become Calcitriol (1,25-dihydroxyvitamin D3). Calcitriol acts as a nuclear receptor agonist, binding to the ubiquitous Vitamin D Receptor (VDR), which then forms a heterodimer complex with the Retinoid X Receptor (RXR). This complex binds to DNA's Vitamin D Response Elements (VDREs) to modulate gene transcription.

This genomic activity governs the Mineral Homeostasis Pathway. In the gut, it upregulates transport proteins (e.g., TRPV6) to enhance the intestinal absorption of calcium and phosphate. In the parathyroid gland, it engages in endocrine feedback modulation by inhibiting Parathyroid Hormone (PTH) gene synthesis. These actions stabilize the systemic concentrations of circulating minerals, a fundamental requirement for skeletal integrity and various cellular processes, including generalized immune system performance.

Dosage and Administration Information

The administration of Dynavit D3 (Colecalciferol) is primarily oral and is structured to ensure proper intake and absorption. Dosing must be individualized and is typically categorized into two phases: maintenance and deficiency treatment. For ongoing use, standard maintenance doses often range from 600 IU to 2,000 IU daily. Higher doses, such as 50,000 IU, may be prescribed weekly for a fixed duration of six to eight weeks to correct a deficiency, which is then followed by the standard maintenance regimen. Long-term treatment with higher strengths requires close medical supervision and regular monitoring of serum levels.


Administration Scope Official Guideline
Route & Timing The medicine is taken by mouth and should be administered with the main meal of the day to maximize the absorption of this fat-soluble compound.
Handling Non-chewable tablets and capsules must be swallowed whole and should not be crushed or chewed. Liquid formulations require the use of a calibrated measuring device provided in the package to ensure the dose is accurate.
Population Rules High-strength formulations are not recommended for the pediatric population. Use is restricted or contraindicated in patients with severe renal impairment.
Missed Dose If a scheduled dose is missed, it should be taken as soon as the patient remembers, unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped to prevent doubling.

The official instructions define a clear sequence that governs the medicine's use, emphasizing the importance of both the dose amount and the specific intake conditions. This protocol shifts the patient from a loading course to a lower, sustained dose.

Recent Clinical Evidence

Dynavit D3: Recent Clinical Evidence


Evidence for Use in Treating Vitamin D Deficiency

Research involving Colecalciferol has focused on its use for addressing low Vitamin D levels, including data from long-term clinical use and short-term randomized controlled trials (RCTs). These studies primarily measured the change in the key biomarker, serum 25-hydroxyvitamin D [25(OH)D] concentrations, in adults and adolescents with low baseline levels. Studies reported measurements of an increase in 25(OH)D levels in the observed populations. What is still uncertain is the long-term stability of the corrected levels and how deficiency is defined across varying regulatory guidelines.


Evidence for Use in Bone Health Conditions

The evidence base includes clinical trials, observational studies, and systematic reviews that examined bone health outcomes, such as for rickets in children and osteomalacia in adults. Study outcomes examined included assessing bone mineralization and monitoring changes in Bone Mineral Density (BMD). Studies reported measurements of changes in skeletal appearance and bone markers, but many trials reported the use of Colecalciferol in combination with calcium. The contribution of Colecalciferol alone is not always clearly separated in the existing trial reports.


Evidence as Adjunctive Therapy for Osteoporosis

Colecalciferol has been evaluated in long-term RCTs and meta-analyses as a supportive measure alongside primary treatments for osteoporosis (thinning bones). These studies measured high-level outcomes such as the frequency of incident fractures (including hip and non-vertebral fractures) and changes in BMD in older adults. Findings were mixed when considering different populations. The findings were not consistent when Colecalciferol was studied alone in healthier, community-dwelling older adults, and the influence of co-administered calcium is often challenging to distinguish.


Study Limitations and Uncertainty

Research has explored specific patient groups, particularly children and older adults, but evidence is limited in other specialized subgroups with complex coexisting conditions. Follow-up durations were limited in some early studies. The evidence highlights an inconsistency of findings regarding fracture incidence in low-risk populations when the compound is used without calcium, and current published research often lacks comprehensive data to explore outcomes beyond bone health.

Key Studies & References

  1. Colecalciferol (Vitamin D3) Pharmacological Overview (NIH StatPearls)

Frequently Asked Questions (FAQ)

Common questions about Dynavit D3 (FAQ)


Q: Is Dynavit D3 the same as just taking a standard Vitamin D supplement?

Dynavit D3 (Colecalciferol) is the same active compound found in many standard supplements. Official documents indicate that this compound is available both as a dietary supplement and as a prescription medicine in different strengths and formulations. The decision on prescription status and appropriate strength is based on the specific condition or deficiency being addressed.

Q: Do I need a prescription to buy Dynavit D3?

According to regulatory status, products containing Colecalciferol (Vitamin D3) can be available both over-the-counter (OTC) as a general supplement and via a prescription in higher-strength formulations. Whether a prescription is required is determined by the product’s specific dosage and the local regulatory classification where it is dispensed.

Q: What is the difference between Dynavit D3 and calcitriol?

Regulatory documents describe the medicine, Colecalciferol (Vitamin D3), as a precursor or prohormone. It must be converted in the body, primarily by the liver and then the kidney, into the biologically active form called calcitriol. Calcitriol is the hormone that carries out the main functions of Vitamin D in the body.

Q: Does Dynavit D3 work right away, or does it take time to notice effects?

Official information indicates that this substance is a prohormone that requires a sequential metabolic activation process in the body before it becomes fully active. This process suggests that the intended therapeutic effect is not immediate but depends on the time it takes for the body to complete the conversion.

Q: Can Dynavit D3 make me feel tired or lethargic?

Official documents do not list fatigue (tiredness) as an uncommon or rare adverse reaction when the medicine is used at typical therapeutic doses. However, this symptom has been reported in cases of acute or chronic overdose that lead to high blood calcium levels (hypercalcaemia).

Q: Do antacids affect how well Dynavit D3 is absorbed?

Regulatory warnings mention that drugs which impair the absorption of fat-soluble vitamins, such as certain laxatives, may reduce the effectiveness of Colecalciferol. For specific over-the-counter antacids, review of the potential effects with a healthcare professional is recommended in official sources.

Q: Why do some people with kidney issues take Dynavit D3?

In some chronic kidney conditions, the kidney's ability to activate Vitamin D is reduced. Official guidance indicates that while Colecalciferol use may be restricted in severe kidney impairment, it is often administered in earlier stages to help address Vitamin D deficiency and manage associated mineral metabolism issues.

Q: Are there any known issues with fertility and Dynavit D3?

Official drug labels state that there is no known potential mutagenic or carcinogenic activity for Colecalciferol. Regulatory sources generally provide no definitive safety signal regarding human fertility, with the drug primarily monitored for use during pregnancy and lactation.

Q: Is the safety of Dynavit D3 monitored after it has been approved?

Yes. According to regulatory sources, all approved medicines are subject to post-authorization safety monitoring through systems like pharmacovigilance. This monitoring system relies on the reporting of any suspected adverse reactions to the relevant national health authority.

Q: Can people who are lactose intolerant take Dynavit D3?

This depends on the inactive ingredients (excipients) used in your specific product's formulation. Official drug labeling lists these excipients, such as lactose, which are used as fillers or stabilizers. Information about these ingredients allows individuals with concerns, such as lactose intolerance, to determine the appropriate formulation.

Q: How is Dynavit D3 different from other types of Vitamin D?

Dynavit D3 is the chemical form known as Colecalciferol. The other common type is Vitamin D2 (Ergocalciferol). Scientific sources cited in official documents note that Colecalciferol is often observed to be more potent than Vitamin D2 (Ergocalciferol) in raising and maintaining blood levels of Vitamin D.

Q: What does 'contraindicated' mean for Dynavit D3?

A contraindication is a condition or situation where regulatory authorities state the medicine should absolutely not be used because the potential risk of harm outweighs any potential benefit. For this medicine, examples include pre-existing high blood calcium (hypercalcaemia) or high Vitamin D levels (hypervitaminosis D).

Q: Is there a generic version of Dynavit D3 available?

Yes. The active ingredient, Colecalciferol, is widely available under various generic names in addition to brand names. It is also sold as a non-prescription dietary supplement.

Q: Are headaches a commonly reported side effect of Dynavit D3?

Headache is not listed in official documents as a common, uncommon, or rare side effect at therapeutic doses. However, headache has been reported as a symptom that can occur in cases of acute or chronic overdose leading to hypervitaminosis D.

Q: Is it necessary to avoid sun exposure while on Dynavit D3?

The body naturally produces Colecalciferol from sunlight. Regulatory warnings advise that the concurrent use of high doses of this medicine with excessive exposure to strong sunlight may increase the risk of hypercalcaemia (excess calcium). Monitoring of the total Vitamin D intake, including exposure from the sun, is part of the overall management strategy.

Q: Can Dynavit D3 be used by individuals with certain autoimmune conditions?

Official drug labels state that caution is necessary for patients with sarcoidosis, a chronic inflammatory condition often involving the immune system. This condition can increase the conversion of Colecalciferol to its active form, potentially raising the risk of hypercalcaemia. Other specific autoimmune conditions are not generally addressed.

Q: Are there religious or cultural restrictions on the ingredients in Dynavit D3?

Official product information is important because some capsule or tablet formulations may contain inactive ingredients like gelatine, which is often sourced from animals. This means certain formulations may be unsuitable for individuals adhering to vegetarian, vegan, kosher, or halal diets. The manufacturer’s excipient list provides the information needed to determine suitability for individuals following specific religious or cultural dietary restrictions.

Q: Does alcohol consumption interfere with Dynavit D3?

The combination of a single dose of Colecalciferol and alcohol is not listed as a significant interaction. However, official sources note that chronic alcoholism can impair the liver's ability to metabolize Vitamin D, potentially affecting the medicine's absorption and activation.

Q: What is the main benefit of using a pharmaceutical Vitamin D like Dynavit D3?

Pharmaceutical formulations (prescription or high-dose OTC) are regulated medicines used to specifically treat or prevent confirmed Vitamin D deficiency or related conditions. Official regulation ensures a standardized strength and quality that may be necessary to meet therapeutic goals beyond general health supplementation.

Q: Are there any specific food items that must be avoided when taking Dynavit D3?

Regulatory sources indicate that sudden increases in the consumption of food items that are very high in calcium and/or phosphorus should be avoided. This is because excessive intake could increase the risk of toxicity (hypercalcaemia) in combination with the Colecalciferol.

Q: How long does Dynavit D3 stay in the body after stopping use?

According to official pharmacokinetic data, the Colecalciferol itself has a half-life of about 24 hours. However, the main circulating form, 25-hydroxyvitamin D, has a much longer half-life of several weeks (around two months), meaning the effects on blood levels persist for a prolonged period after stopping the medicine.

Q: What is the purpose of the inactive ingredients in Dynavit D3 tablets?

The inactive ingredients, known as excipients, are listed in official product information and serve important roles. These can include stabilizing the active drug, acting as fillers or binding agents, and helping to control the rate at which the medicine is absorbed by the body.

Q: What is the significance of the D3 in the drug name?

The D3 refers to the chemical form, Colecalciferol. This is the form of Vitamin D naturally produced in the human skin upon sun exposure and is used in the medication. Scientific sources note that Colecalciferol is often observed to be more potent than Vitamin D2 (Ergocalciferol) in raising and maintaining blood levels.

Q: Does Dynavit D3 interact with herbal supplements like St. John's Wort?

Official drug labels warn about potential interaction with medicines that affect the metabolism of Vitamin D in the liver. Since St. John's Wort is a known enzyme inducer, the risk of reduced effectiveness due to St. John's Wort requires review by a healthcare professional.

Q: What patient safety programs are in place for Dynavit D3?

Specific national patient safety programs are managed by regulatory bodies (e.g., the FDA or MHRA) to collect and analyze reports of side effects or issues experienced with the medicine after it has been authorized. This process, called pharmacovigilance, is in place to ensure continuous risk monitoring.

Q: What common supplements should I be concerned about taking with Dynavit D3?

Regulatory warnings require caution and monitoring when taking high doses of calcium or magnesium (especially in chronic renal dialysis). Supplements that impair absorption (like mineral oil) or those that affect liver enzymes may also pose a risk. Official documents state that the safety of all supplement combinations should be reviewed by a healthcare provider.

Q: How soon after starting Dynavit D3 should I expect my Vitamin D levels to change?

Clinical data cited in official sources indicate that blood levels of the key Vitamin D biomarker, 25-hydroxyvitamin D, often indicate measurable changes within the first 4 to 6 weeks of starting therapy. Achieving the final target level may take a longer time.

Q: Can I take other vitamin supplements while using Dynavit D3?

Co-administration with other Vitamin D metabolites or high doses of calcium requires close monitoring for additive effects on calcium levels. While there are no specific warnings for non-Vitamin D supplements (e.g., Vitamin C or B complex), regulatory guidance states that the combination use of any supplement should be reviewed by a healthcare provider.

Q: What if I experience mild stomach upset after taking Dynavit D3?

General stomach upset is not specifically listed as a common adverse reaction in official drug information. However, gastrointestinal symptoms like nausea and vomiting are listed as potential early symptoms of high calcium levels (hypercalcaemia) that are associated with the medicine.

Q: Can older adults or seniors use Dynavit D3?

Yes, Colecalciferol is commonly used by older adults. However, regulatory guidance emphasizes that careful consideration and review of dosage and monitoring by a healthcare professional is necessary due to the high prevalence of co-existing conditions and use of other medicines in this population.

Q: Why does the packaging for Dynavit D3 mention liver health?

Official information regarding the medicine’s mechanism of action states that the liver is required to perform the first enzymatic activation step of the precursor substance. This conversion is critical for the medicine to work properly in the body.

How should Dynavit D3 be stored and disposed of?

Storage and Disposal Requirements

Dynavit D3 (Colecalciferol) must be stored under specific environmental and temperature controls to maintain its stability, as mandated by official labeling.

Storage Classification Requirement
Temperature Store at controlled room temperature (20 C to 25 C), permitting excursions between 15 C and 30 C.
Environmental Protection Protect from light and moisture; avoid excessive heat and do not freeze.
Container Rule Must be kept in a tight, light-resistant container. Do not use if the tamper-evident seal is missing or broken.
Child Safety Keep this and all medications out of the reach of children.
Disposal Dispose of unused or expired product strictly according to local regulations for pharmaceutical waste.

Liquid formulations require additional protection from direct light after opening.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dynavit D3 found in:

A-Z Index: